Tenders Are Invited For Services Provided By Medical Laboratories – Extensive Pharmacogenetic Panel, Islab in Finland

Work Detail

Services Provided By Medical Laboratories – Extensive Pharmacogenetic Panel, Islab. The Object Of The Acquisition Is The Islab Wellness Companys Extensive Pharmacogenetic Panel. The Results Of The Panel Are Forwarded To Islab Via Hl7 Connection And A Finnish Statement Is Given On The Results Of The Panel. A Broad Pharmacogenetic Panel Refers To A Gene Panel That Examines More Than 12 Clinically Significant Genes Affecting Drug Therapy. The Results And Statement Must Be Compatible With Kanta Archiving. The Acquisition Complements The Possibilities For Islabs Customers To Acquire Pharmacogenetic Studies. The Estimated Annual Research Volume Is 400, Which Is Based On The Research Volumes Of Previous Years. The Customer Does Not Have A Quantity Purchase Obligation, But The Estimated Amount Is Given To Make The Offer Easier. The Procurement Contract Period Begins On February 1, 2026. The Agreement Is Valid Indefinitely With A Notice Period Of Six (6) Months. In Procurement, 1 Supplier Is Selected Using An Open Procedure.

Contact Information